Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Advisory

Scribe Therapeutics to Participate in Four Upcoming Conferences


Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Designtm platform for genetic medicine, today announced it will participate in four upcoming conferences.

Scribe co-founder and CEO Benjamin Oakes will participate in a fireside chat at 12 p.m. ET on Monday, Nov. 21, 2022, at the BMO Capital Markets Epigenome Editing Event.

The following week, the Scribe management team will participate in the virtual Evercore ISI HealthCONx Conference taking place from Tuesday, Nov. 29 to Thursday, Dec. 1, 2022.

Scribe Chief Financial Officer David Parrot will present at the Piper Sandler Annual Healthcare Conference at 10:50 a.m. ET on Tuesday, Nov. 29, 2022 in New York, NY.

Scribe co-founder and Vice President of Platform Brett Staahl will present at the CRISPR 2.0 Summit in Boston, Mass. His presentation titled "Honing Novel Gene Editing Tools for Improved Activity, Specificity and Deliverability" will take place during the "Strategies to Refine CRISPR Tools" session at 8 a.m. ET on Wednesday, Nov. 30, 2022.

About Scribe Therapeutics

Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease. Founded by CRISPR inventors and leading molecular engineers Benjamin Oakes, Brett Staahl, David Savage, and Jennifer Doudna, Scribe is overcoming the limitations of current genome editing technologies by developing custom engineered enzymes and delivery modalities as part of a proprietary, evergreen CRISPR by Designtm platform for genetic medicine. The company is backed by leading individual and institutional investors including Andreessen Horowitz, Avoro Ventures and Avoro Capital Advisors, OrbiMed Advisors, Perceptive Advisors, funds and accounts advised by T. Rowe Price Associates, Inc., funds managed by Wellington Management, RA Capital Management, and Menlo Ventures. To learn more about Scribe's mission to engineer the future of genetic medicine, visit www.scribetx.com.


These press releases may also interest you

at 10:53
Awardco, the leading provider of employee recognition and rewards solutions, is pleased to announce the appointment of Ryan Jackson as President. With over 15 years experience in leadership roles at industry-leading companies Qualtrics and MX, Ryan...

at 10:48
From mining critical minerals to building cars and batteries, Canadian businesses and workers are attracting historic investments to help secure and create jobs, grow our economy, and keep our air clean. In the last four years, automotive and battery...

at 10:45
As Drax stakeholders gather for the giant biomass company's annual general meeting on April 25 in London, community leaders, scientists, and activists on both sides of the Atlantic are calling for an end to the logging, wood-pellet making, and...

at 10:45
Connected Nation (CN) announced today that it is working with three nonprofits across the country to distribute 5,000 eero (an Amazon Company) mesh wifi devices to households, families, and individuals who are in need of faster and more reliable...

at 10:37
With threats to schools at an all-time high, ZeroNow, the school safety stakeholder community, is launching the National Council of School Safety Directors to advocate for a dedicated School Safety Director in K-12 school districts nationwide....

at 10:36
SDR Ventures is pleased to announce that Cablenet Aerospace, Inc. ("Cablenet" or "the Company") has been acquired by Interconnect Solutions Company (ISC), a portfolio company of Tide Rock. SDR served as the exclusive sell-side advisor to Cablenet and...



News published on and distributed by: